drugset / Trial / NCT02283827
Open-label Drug Interaction Study Between Eslicarbazepine Acetate and Phenytoin.
RandomizedParallel-groupOpen-labelTreatment
Summary
Single centre, open-label, multiple doses, two parallel study groups each receiving two formulations in a one-sequence design
Timeline
- Start
- 2007-01
- Primary completion
- 2007-03
- Completion
- 2007-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Eslicarbazepine acetate | Unknown | 1200 mg | — |
| Subject | Phenytoin | Unknown | 300 mg | — |